CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow

More than 110 student scientists from around California showcased their enthusiasm, passion and “spark” for regenerative medicine and stem cell research at this year’s annual CIRM SPARK Conference.   Hosted by Cedars Sinai from Aug. 8-9 in Los Angeles, this year’s event showcased the extraordinary potential of high school students who are poised to become the … Continue reading CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow

Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions 

Yanhong Shi, Ph.D., Beckman Research Institute of City of Hope.  Progress is being made to treat cancer patients suffering from degenerative brain diseases.   Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have developed universal donor stem cells that could one day provide lifesaving therapy to … Continue reading Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions 

Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency

The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency. Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative … Continue reading Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency

Novartis acquisition validates CIRM’s impact on cystinosis treatment

Dr. Stephanie Cherqui The future looks brighter for cystinosis patients and their families.   As one of 7,000 rare diseases, cystinosis causes an abnormal build-up of the amino acid cystine that can lead to organ failure and premature death. With little to no treatment options, children and young adults primarily affected by the condition often have … Continue reading Novartis acquisition validates CIRM’s impact on cystinosis treatment

#Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters

April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease.  In addition to highlighting our commitment to funding research for Parkinson's Disease, we're also giving patients and patient advocates the opportunity to … Continue reading #Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters

CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign 

April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease.  What is Parkinson’s Disease?  Parkinson's disease (PD) is a neurodegenerative disease that affects nearly 1 million people in the United States … Continue reading CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign 

Meet CIRM’s growing world class team 

The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world. CIRM is rebuilding and expanding its team to meet new challenges and advance the mission of the Agency.  Rafael Aguirre-Sacasa and Koren Temple-Perry join the growing … Continue reading Meet CIRM’s growing world class team 

CIRM welcomes two additions to its leadership team

Left to right: Rafael Aguirre-Sacasa, General Counsel and Koren Temple-Perry, Senior Director of Marketing Communications The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world.  CIRM is pleased to welcome two new members to its … Continue reading CIRM welcomes two additions to its leadership team

CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries

The California Institute for Regenerative Medicine (CIRM) has awarded a $2.7 million research grant to Scripps Health to investigate the use of stem cells to engineer rotator cuff tendons in the lab that can then be used to repair common shoulder injuries.   The rotator cuff is a group of four muscles and their attached tendons, … Continue reading CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries

Meshing a passion for medicine with stem cell research

Kevin Brown is an adventurer at heart. He was a pre-med student when he found a unique way to combine his passion for medicine in neuroscience with his natural inclination to explore and discover through scientific research. A 2022 graduate of the California Institute for Regenerative Medicine’s (CIRM) Bridges to Stem Cell Research and Therapy … Continue reading Meshing a passion for medicine with stem cell research